Erratum: Retraction for Wu et al., volume 91, 2004, p. 1734-1747(J Neurophysiol (2004) 91 (1734-1747) DOI: 10.1152/jn.00791.2003);Hypothalamus-Brain Stem Circuitry Responsible for Vagal Efferent Signaling to the Pancreas Evoked By Hypoglycemia in Rat

Journal of Neurophysiology

Volumn 91, Issue 4, 2004, Pages 1734-1747

  Wu, Xiaoyin ^a   Gao, Jun ^a   Yan, Jin ^a   Owyang, Chung ^a   Li, Ying ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NEUROPEPTIDE Y DERIVATIVE; OREXIN A; OREXIN A RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DECEREBRATION; GLUCOSE HOMEOSTASIS; HYPOGLYCEMIA; HYPOTHALAMUS; MALE; NERVE PROJECTION; NEUROMODULATION; NODOSE GANGLION; NONHUMAN; PANCREAS FUNCTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VAGUS NERVE;

EID: 1542510707     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00791.2003_RET     Document Type: Erratum

References (72)

1. Adachi A, Kobashi M, and Funahashi M. Glucose-responsive neurons in the brainstem. Obes Res 3, Suppl. 5: 735s-740s, 1995.
2. Aynsley-Green A, Biebuyck JF, and Alberti KG. Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia 9: 274-281, 1973.
3. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C, and Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92: 1824-1830, 1993.
4. Bernardis LL and Bellinger LL. The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav 20: 189-287, 1996.
5. Blat S and Malbert CH. The vagus is inhibitory of insulin secretion under fasting conditions. Am J Physiol Endocrinol Metab 281: E782-E788, 2001.
6. Blomqvist G, Gjedde A, Gutniak M, Grill V, Widen L, Stone-Elander S, and Hellstrand E. Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycaemia on cerebral glucose utilization. Eur J Nucl Med 18: 834-837, 1991.
7. Broberger C, De Lecea L, Sutcliffe JG, and Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells from distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402: 460-474, 1998.
8. Buijs RM, Chun SJ, Niijima A, Romijn HJ, and Nagai K. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J Comp Neurol 431: 405-423, 2001.
9. J Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JR, Wilson S, and Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50: 105-112, 2001.
10. Cannon WB, McIuer MA, and Bliss SW. Studies on the condition of activity in endocrine glands. XIII. A sympathetic and adrenal mechanism for mobilizing sugar in hypoglycemia. Am J Physiol 69: 46-66, 1924.
11. Cardin S, Jackson PA, Edgerton DS, Neal DW, Coffey CS, and Cherrington AD. Effect of vagal cooling on the counterregulatory response to hypoglycemia induced by a low dose of insulin in the conscious dog. Diabetes 50: 558-564, 2001.
12. Clarke DD and Sokoloff L. Circulation and energy metabolism of the brain. In: Basic Neurochemistry, edited by Siegel GJ, Agranoff BW, Albers RW, Fisher SK, and Uhler MD. Philadelphia: Lippincott-Raven, 1999, p. 637-669.
13. Coiro V, Passeri M, Rossi G, Camellini L, Davoli D, Marchesi M, Muzzetto P, Minelli R, Bianconi L, Coscelli C, and Chiodera P. Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. Horm Metab Res 21: 102-103, 1989.
14. Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol Endocrinol Metab 264: E149-E155, 1993.
15. Cryer PE. Hypoglycemia: Pathophysiology, Diagnosis, and Treatment. New York: Oxford Univ. Press, 1997.
16. DiRocco RJ and Grill HJ. The forebrain is not essential for sympathoadrenal hyperglycemic response to glucoprivation. Science 204: 1112-1114, 1979.
17. Dunning BE and Taborsky GJ Jr. Neural control of islet function by norepinephrine and sympathetic neuropeptides. Adv Exp Med Biol 291: 107-127, 1991.
18. Farouk M, Geoghegan JG, Pruthi RS, Thomson HJ, Pappas TN, and Meyers WC. Intracerebroventricular neuropeptide Y stimulates bile secretion via a vagal mechanism. Gut 33: 1562-1565, 1992.
19. Ferreira M Jr, Browning KN, Sahibzada N, Verbalis JG, Gillis RA, and Travagli RA. Glucose effects on gastric motility and tone evoked from the rat dorsal vagal complex. J Physiol 536: 144-152, 2001.
20. Fraley GS and Ritter S. Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-D-glucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Endocrinology 144: 75-83, 2003.
21. Frier BM and Fisher BM. Hypoglycaemia in Clinical Diabetes. New York: Wiley, 1999.
22. Geoghegan JG, Lawson DC, Cheng CA, Opara E, Taylor IL, and Pappas TN. Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. Gastroenterology 105: 1069-1077, 1993.
23. Grouzmann E, Comoy E, Walker P, Burnier M, Bohuon C, Waeber B, and Brunner H. Production and characterization of four anti-neuropeptide Y monoclonal antibodies. Hybridoma 11: 409-424, 1992.
24. Havel PJ, Mundinger TO, and Taborsky GJ Jr. Pancreatic sympathetic nerves increase glucagon secretion during severe hypoglycemia in dogs. Am J Physiol Endocrinol Metab 270: 33: E20-E26, 1996.
25. Havel PJ, Parry SJ, Curry DL, Akpan JO, Stern JS, and Gingerich RL. Autonomic nervous system mediation of the pancreatic polypeptide response to insulin-induced hypoglycemia in conscious rats. Endocrinology 130: 2225-2229, 1992.
26. Heller SR and Macdonald IA. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 13: 607-615, 1996.
27. Hevener AL, Bergman RN, and Donovan CM. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 49: 8-12, 2000.
28. Hevener AL, Bergman RN, and Donovan CM. Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus. Diabetes 50: 399-403, 2001.
29. Himmi T, Boyer A, and Orsini JC. Changes in lateral hypothalamic neuronal activity accompanying hyper-and hypoglycemias. Physiol Behav 44: 347-354, 1988.
30. Jackson PA, Cardin S, Coffey CS, Neal DW, Allen EJ, Penaloza AR, Snead WL, and Cherrington AD. Effect of hepatic denervation on the counterregulatory response to insulin-induced hypoglycemia in the dog. Am J Physiol Endocrinol Metab 279: E1249-E1257, 2000.
31. Jones TW, McCarthy G, Tamborlane WV, Caprio S, Roessler E, Kraemer D, Starick-Zych K, Allison T, Boulware SD, and Sherwin RS. Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects. Diabetes 39: 1550-1555, 1990.
32. Jungheim K and Koschinsky T. Glucose monitoring at the thenar: evaluation of upper dermal blood glucose kinetics during rapid systemic blood glucose changes. Horm Metab Res 34: 325-329, 2002.
33. Levin BE, Dunn-Meynell AA, and Routh VH. Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol Regul Integr Comp Physiol 276: R1223-R1231, 1999.
34. Li Y, Hao Y, Zhu J, and Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-CCK-stimulated pancreatic secretion in rats. Gastroenterology 118: 1197-1207, 2000.
35. Li Y, Jiang YC, and Owyang C. Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow. Am J Physiol Gastrointest Liver Physiol 275: G957-G963, 1998.
36. Li Y and Owyang C. Somotostatin inhibits pancreatic enzyme secretion by a central vagal site. Am J Physiol Gastrointest Liver Physiol 265: G251-G257, 1993a.
37. Li Y and Owyang C. Vagal afferent pathways mediate physiological action of cholecystokinin on pancreatic secretion. J Clin Invest 92: 418-424, 1993b.
38. Li Y, Wu X, Zhu J, Yan J, and Owyang C. Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. J Physiol 552: 571-587, 2003.
39. Li Y, Wu X, Zhu JX, and Owyang C. Intestinal serotonin acts as a paracrine substance to mediate pancreatic secretion stimulated by luminal factors. Am J Physiol Gastrointest Liver Physiol 281, G916-G923, 2001.
40. Li Y, Zhu J, and Owyang C. Electrical physiological evidence for high- and low-affinity vagal CCK-A receptors. Am J Physiol Gastrointest Liver Physiol 277: G469-G477, 1999.
41. Liu M, Seino S, and Kirchgessner AL. Identification and characterization of glucoresponsive neurons in the enteric nervous system. J Neurosci 19: 10305-10317, 1999.
42. Liu XH, Morris R, Spiller D, White M, and Williams G. Orexin a preferentially excites glucose-sensitive neurons in the lateral hypothalamus of the rat in vitro, Diabetes 50: 2431-2437, 2001.
43. Michelini LC and Bonagamba LG. Baroreceptor reflex modulation by vasopressin microinjected into the nucleus tractus solitarii of conscious rats. Hypertension 11: 175-179, 1988.
44. Minami S, Kamegai J, Sugihara H, Suzuki N, Higuchi H, and Wakabayashi I. Central glucoprivation evoked by administration of 2-deoxy-D-glucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus. Brain Res Mol Brain Res 33: 305-310, 1995.
45. Nauck MA, Heimesaat M, Behle K, Holst JJ, Nauck MS, Ritzel R, Hufner M, and Schmiegel WH. Effect of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 87: 1239-1246, 2002.
46. Niijima A. An electrophysiological study on the regulatory mechanism of blood sugar level in the rabbit. Brain Res 87: 195-199, 1975.
47. Palkovits M, Zaborszky L, Feminger A, Mezey E, Fekete MI, Herman JP, Kanyicska B, and Szabo D. Noradrenergic innervation of the rat hypothalamus: experimental biochemical and electron microscopic studies. Brain Res 191: 161-171, 1980.
48. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed.). San Diego, CA: Academic Press, 1998.
49. Planche T, Kreshna S, Kombila M, Engel K, Faucher JF, Ngou-Milama E, and Kremsner PG. Comparison of methods for rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 65: 599-602, 2001.
50. Pramming S, Thorsteinsson B, Stigsby B, and Binder C. Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 296: 665-667, 1988.
51. Rosenberg IR, Zambrano VJ, Janowitz HD, and Rudick J. Parasympathetic innervation and pancreatic secretion: the role of the gastric antrum. Ann Surg 183: 247-251, 1976.
52. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Rickson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
53. Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, Schaffalitzky de Muckadell OB, and Stadil F. Vagal cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61: 781-789, 1978.
54. Silver IA and Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 14: 5068-5076, 1994.
55. Siren AL, Vonhof S, and Feuerstein G. Hemodynamic defense response to thyrotropin-releasing hormone injected into medial preoptic nucleus in rats. Am J Physiol Regul Integr Comp Physiol 261: R305-R312, 1991.
56. Smith RB, Edwards JP, and Johnston D. Effect of vagotomy on exocrine pancreatic and biliary secretion in man. Am J Surg 41: 40-47, 1981.
57. Steiner JE. The gustofacial response: observation on normal and anencephalic newborn infants. Symp Oral Sens Percep 4: 254-278, 1973.
58. Strachan MW, Deary IJ, Ewing FM, Ferguson SS, Young MJ, and Frier BM. Acute hypoglycemia impairs the functioning of the central but not peripheral nervous system. Physiol Behav 72: 83-92, 2001.
59. Strubbe JH and Steffens AB. Neural control of insulin secretion. Horm Metab Res 25: 507-501, 1993.
60. Taborsky GJ. Insulin and glucagon secretion in vivo and its neural control. In: The Handbook of Physiology. The Endrocrine System, edited by Jefferson LS, Cherrington AD, and Goodman HM. New York: Oxford Univ. Press, vol. II, 2001.
61. Tang PC. Levels of brain stem and diencephalon controlling micturition reflux. J Neurophysiol 18: 583-595, 1995.
62. Ter Horst GJ, de Boer P, Luiten PG, and van Willingen JD. Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience 31: 785-797, 1989.
63. Unger J, McNeill TH, Moxley RT 3rd, White M, Moss A, and Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain, Neuroscience 31: 143-157, 1986.
64. Waynforth HB. Intracerebral injection. In: Experimental and Surgical Technique in the Rat, edited by Waynforth HB, New York: Academic Press, 1994.
65. Wettergren A, Wojdemann M, and Holst JJ. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol Gastrointest Liver Physiol 275: G984-G992, 1998.
66. Williams G, Bing C, Cal XJ, Harrold JA, King PJ, and Liu XH. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 74: 683-701, 2001.
67. Wu YX, Zhao Y, Owyang C, and Li Y. Neurocircuitry in the dorsal motor nucleus of vagus modulating efferent signaling to the pancreas (Abstract). Digestion 63: 7, 2001.
68. Wu YX, Zhao Y, Owyang C, and Li Y. Characterization of the neuronal circuitry in the dorsal motor nucleus of the vagus modulating vagal efferent signaling to the pancreas: electrophysiological and immunocytochemistry studies (Abstract), Gastroenterology 122: 4, 37, 2002.
69. Yettefti K, Orsini JC, and Perrin J. Characteristics of glycemia-sensitive neurons in the nucleus tractus solitarii: possible involvement in nutritional regulation. Physiol Behav 61: 93-100, 1997.
70. Yoshimatsu H, Niijima A, Oomura Y, Yamabe K, and Katafuchi T. Effects of hypothalamic lesion on pancreatic autonomic nerve activity in the rat. Brain Res 303: 147-152, 1984.
71. Yuan PQ and Yang H. Neuronal activation of brain vagal-regulatory pathways and upper gut enteric plexuses by insulin hypoglycemia. Am J Physiol Endocrinol Metab 283: E436-E448, 2002.
72. Zhu JX, Wu XY, Owyang C, and Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol 530: 431-442, 2001.